Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2010
06/16/2010CN101143138B Paracetamol and pseudoephedrine hydrochloride tablets made by dry powder direct tabletting
06/16/2010CN101002912B Method for preparing Yueshu dripping pills to treat dysmenorrhea
06/16/2010CN101002625B Beverage for relieving summer heat, and its preparing process
06/15/2010US7737285 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction
06/15/2010US7737264 Oligomeric compounds for the modulation HIF-1α expression
06/15/2010US7737178 Administering a combination of an omega-3 fatty acid and aspirin, to a patient suffering from inflammation, arthritis or cardiovascular diseases; reduced side effects; 13-hydroxy-DHA (13-hydroxy-DHA)
06/15/2010US7737161 such as 5-amino-N-(5-chloropyridin-2-yl)-3-{[(trans-4-pyrrolidin-1-ylcyclohexyl)carbonyl]amino}furo[3,2-b]pyridine-2-carboxamide, used as activated blood coagulation factor X inhibitors
06/15/2010US7737155 nicotinic receptor agonist useful for treating metabolic syndrome, dyslipidemia, cardiovascular diseases, disorders of the peripheral and central nervous system, hematological diseases, cancer, inflammation, respiratory diseases, gastrointestinal diseases, diabetes, and non-alcoholic fatty liver diseases
06/15/2010US7737148 Hydroxyiminopiperazines administered to animals as analgesics; inhibitors of vanilloid receptors
06/15/2010US7737143 such as 6-(1H-Benzimidazol-1-yl)-N-benzylpyrazin-2-amine, used as antidiabetic, anticarcinogenic and antiarthritic agents or for treating autoimmune diseases
06/15/2010US7737139 useful in inhibiting the chernotactic activation of neutrophils, induced by the interaction of Interleukin-8 (IL-8) with chemokine membrane receptors
06/15/2010US7737127 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
06/15/2010US7736679 comprises curcumin and an essential oil of turmeric
06/15/2010US7736666 Consists of naproxen, a butyl spacer and a nitrogen oxide (NO)-releasing nitrate group, linked together into a single molecule; useful as antiinflammatory agent and an analgesic
06/15/2010US7736655 Neuroprotectants; angoigenesis inhibitors; transcription factors; host cells
06/15/2010US7736622 Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
06/15/2010CA2518224C Novel isothiazolopyrimidinones and isoxazolopyrimidinones and uses thereof
06/15/2010CA2493391C Novel thiophene glycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
06/15/2010CA2463668C Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof
06/15/2010CA2440648C Imidazolidine derivatives, their preparation, and their use as antinflamatory agent
06/15/2010CA2393650C Novel 1,8-naphthyridin-2(1h)-one derivatives
06/15/2010CA2335505C Novel triterpenoids and their use for the treatment and prevention of cancer, inflammatory disorders, and neurodegenerative disease
06/15/2010CA2328922C Terminally-branched polymeric linkers and polymeric conjugates containing the same
06/10/2010WO2010065491A2 Methods of treating inflammatory disorders
06/10/2010WO2010064737A1 Heterocyclic compound and use of the same
06/10/2010WO2010064714A1 Nutrient composition
06/10/2010WO2010064707A1 2h-chromene compound and derivative thereof
06/10/2010WO2010064705A1 Novel 7-substituted dihydropyranopyrimidine derivative having h4 receptor antagonistic activity
06/10/2010WO2010064697A1 Anti-nr10 antibody, and use thereof
06/10/2010WO2010064665A1 Therapeutic agents
06/10/2010WO2010064597A1 Piperidine derivative
06/10/2010WO2010064456A1 Anti-nr10 antibodies and utilization of the same
06/10/2010WO2010064441A1 Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof
06/10/2010WO2010064254A1 Novel multi purpose composition
06/10/2010WO2010064020A1 Imidazopyridine compounds
06/10/2010WO2010045415A3 Topical nsaid compositions having sensate component
06/10/2010WO2010036065A9 Pharmaceutical composition for preventing and treating inflammatory diseases, containing an ethyl acetate fraction of dried extract of trachelospermi caulis as an active ingredient, and method for producing the fraction
06/10/2010WO2010009111A4 A drug depot implantable within a synovial joint
06/10/2010WO2010002956A3 Heterocyclic derivatives as modulators of ion channels
06/10/2010WO2009121514A3 Self-destructing transdermal therapeutic system having improved functionality and efficacy
06/10/2010US20100144882 treating acute post-bunionectomy pain with diclofenac potassium
06/10/2010US20100144872 New Methylenebisphenyl Compounds Useful in the Treatment of Inflammation
06/10/2010US20100144827 Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof
06/10/2010US20100144774 Heterocyclic spiro-compounds
06/10/2010US20100144765 5,6-trimethylenepyrimidin-4-one compounds
06/10/2010US20100144764 Pyrimidinedione derivatives and methods of use thereof
06/10/2010US20100144758 Azaindole p2x3 and p2x2/3 modulators
06/10/2010US20100144757 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
06/10/2010US20100144756 Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
06/10/2010US20100144748 Methods involving aldose reductase inhibitors
06/10/2010US20100144742 Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
06/10/2010US20100144740 Synergistic combinations of vr-1 antagonists and cox-2 inhibitors
06/10/2010US20100144727 Oxazolidine and Morpholine Carboxamide Derivatives as P2X7 Modulators
06/10/2010US20100144723 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione
06/10/2010US20100144721 Inhibitors of c-met and uses thereof
06/10/2010US20100144665 Treatment of statin side effects
06/10/2010US20100144649 Compounds for enzyme inhibition
06/10/2010US20100144648 Compounds for enzyme inhibition
06/10/2010US20100144647 Dual Acting Prodrugs
06/10/2010US20100144642 Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions
06/10/2010US20100144632 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity
06/10/2010US20100144631 Concentrated Protein Preparations of Bone Morphogenetic Proteins and Methods of Use Thereof
06/10/2010US20100144615 Nucleotide sequence encoding a modulator of nf-kb
06/10/2010US20100144607 Anti-inflammatory and antiallergic cyclic peptides
06/10/2010US20100144599 Vegf pathway blockade
06/10/2010US20100143460 Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof
06/10/2010US20100143437 Implantable analgesic
06/10/2010US20100143424 Casein nanoparticle
06/10/2010US20100143368 Human Antibodies That Bind Cd22 And Uses Thereof
06/10/2010US20100143360 Human vascular endothelial growth factor 2
06/10/2010US20100143357 Uses of Mammalian Cytokine; Related Reagents
06/10/2010US20100143355 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same
06/10/2010US20100143353 POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (lgG) AND METHODS OF USING THE SAME
06/10/2010US20100143349 Humanized anti-rage antibody
06/10/2010US20100143328 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
06/10/2010US20100143324 Method for treatment of cancers or inflammatory diseases
06/10/2010US20100143312 Treatment of diseases, disorders or conditions of the lung using placental cells
06/10/2010US20100143270 Therapeutic cotinine compositions
06/10/2010US20100143269 Pharmaceutical compositions for the treatment of asthma
06/10/2010CA2745356A1 2h-chromene compound and derivative thereof
06/10/2010CA2710264A1 Anti-nr10 antibody and use thereof
06/09/2010EP2194044A1 Quinolone derivative
06/09/2010EP2193788A1 Pharmaceutical compositions comprising colloidal silicon dioxide
06/09/2010EP2193133A2 Imidazolothiadiazoles for use as protein kinase inhibitors
06/09/2010EP2193127A1 Benzothiazole compounds
06/09/2010EP2193119A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
06/09/2010EP2192900A2 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
06/09/2010EP2192896A1 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders
06/09/2010EP1497273B1 Hydroxamic acid derivatives
06/09/2010EP1385864B1 Anti-VEGF-2 antibodies
06/09/2010EP0951295B1 Compositions for use in inhibiting of alpha-v-beta3 mediated angiogenesis
06/09/2010CN1880319B Tropane derivatives as CCR5 modulators
06/09/2010CN1780835B Novel fused heterocycles and uses thereof
06/09/2010CN1662511B Pharmaceutical salts of reboxetine
06/09/2010CN101724934A Medicinal fibre used for treating cutaneous inflammation and pain, preparation and application thereof
06/09/2010CN101724539A Formula of health-care wine and preparation method thereof
06/09/2010CN101724075A Remodeling and glycoconjugation of peptides
06/09/2010CN101724071A Single domain antibodies against TNFRl and methods of use therefor
06/09/2010CN101724070A humanized anti-ngf antibodies
06/09/2010CN101724066A Mimic polypeptides of myeloid differentiation protein-2 and application thereof
1 ... 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 ... 1272